News | September 21, 2023
Venus Remedies gets marketing approval for gemcitabine and docetaxel in Serbia
With this, the company has secured 511 marketing approvals for its oncology products across 66 countries
With this, the company has secured 511 marketing approvals for its oncology products across 66 countries
The partnership is part of BioNTech’s strategy to develop novel prophylactic vaccines for the prevention of high-medical-need infectious diseases
The market capitalization of the company stood at Rs. 7,000 crore +
Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
The brand has launched 6 new range of products to provide a complete pregnancy care solution
Sets price band at ?695 to ?735 per Equity Share
The three-week travel campaign is aimed at spreading awareness about infertility and making Karnataka infertility-free
Jupiter has filed its draft herring prospectus (DRHP) with the market regulator in May this year, to float its IPO
Global Initiative on Digital Health launched at the G2O Health Minister’s Meeting
Continuous learning is not just an option but a responsibility that every healthcare professional must shoulder
Subscribe To Our Newsletter & Stay Updated
